We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Glanbia Plc | LSE:GLB | London | Ordinary Share | IE0000669501 | ORD EUR0.06 (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.79 | -4.28% | 17.65 | 16.86 | 18.44 | 1,125 | 16:35:13 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 5.43B | 344.5M | 1.2652 | 14.57 | 5.02B |
TIDMGLB
RNS Number : 1288Z
Glanbia PLC
20 January 2022
Glanbia plc Transaction in Own Shares
20 January 2022, Glanbia plc ("Glanbia" or "the Company"), the global nutrition Company has been informed that Glanbia Co-operative Society ("the Co-op") has completed the sale of approximately 5.75 million ordinary shares in the Company (the "Shares"), representing around 2 percent of the Company's issued share capital, for a total consideration of approximately EUR70 million (the "Equity Placement"). Concurrently with the Equity Placement, the Co-op placed EUR 250 million senior secured bonds and certain subscribers to these bonds placed existing Shares (the "Delta Shares") together with the Equity Placement (the "Placement")
The price per Share in the Placement was EUR12.25 and was determined by a book-build offering to institutional investors with settlement expected to occur on or around 24 January 2022.
Pursuant to the Company's existing authority to repurchase shares, the Company has participated in the Placement via Glanbia's broker Davy and today purchased 2,527,152 Shares (representing around 0.9 percent of the Company's existing issued share capital), at a price of EUR12.25 per Share (the "Buyback"). The Shares purchased in the Buyback will be cancelled. Following settlement of the above transaction and subsequent share cancellation Glanbia will have 284,022,805 ordinary shares in issue.
The purchase of shares from the Co-op as part of the Buyback constitutes a related party transaction for the Company under the Euronext Listing Rules ("Euronext LR") and the FCA Listing Rules ("FCA LR"). Pursuant to paragraph 11.1.15 (2)(a) of the Euronext LR and paragraph 11.1.10 (2)(b) of the FCA LR, Davy Corporate Finance confirms that the terms of the Buyback with the related party, are fair and reasonable as far as the shareholders of the Company are concerned.
The Buyback completed today by the Company is incremental to the ongoing EUR50 million share repurchase programme announced on 8 December 2021.
ENDS
For further information please contact:
Glanbia plc +353 56 777 2200
Mark Garvey, Group Finance Director
Liam Hennigan, Group Director of Strategic Planning & Investor Relations: +353 86 046 8375
Martha Kavanagh, Head of Corporate Communications: +353 87 646 2006
Davy +353 1 679 7788
Ivan Murphy/Ronan Veale
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSBDGDBIGDDGDG
(END) Dow Jones Newswires
January 20, 2022 07:11 ET (12:11 GMT)
1 Year Glanbia Chart |
1 Month Glanbia Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions